Investigation of amyloid‐beta 42 levels in human nasal discharge fluid from healthy and Alzheimer’s discovers diagnostic values
Da Hae Jung, Gowoon Son, Shengmin Wang, Hyun Kook Lim, Cheil Moon · 2025
Read Investigation of amyloid‐beta 42 levels in human nasal discharge fluid from healthy and Alzheimer’s discovers diagnostic values by Da Hae Jung, Gowoon Son, Shengmin Wang, Hyun Kook Lim, Cheil Moon (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712357.txt.
Description
A simple nose test could one day help flag Alzheimer's disease early, when drugs help most. Da Hae Jung, Gowoon Son, Shengmin Wang, Hyun Kook Lim, and Cheil Moon measured a brain-linked protein in nasal fluid in 2025. Samples came from one hundred sixty-one people who also took memory tests and brain scans. The protein, called Aβ42, builds up in the brains of people with the disease.
People in the third-highest group of nasal levels held the most patients with the disease. That group also showed the worst scores on thinking tests. Nasal levels tracked with brain scan results and with the risk of the disease. The authors say the test looks promising for diagnosis and risk checks, though more work is needed before clinic use.
Catalog record
| CREATOR | Da Hae Jung, Gowoon Son, Shengmin Wang, Hyun Kook Lim, Cheil Moon |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |